152 related articles for article (PubMed ID: 2936068)
21. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
Bero LA; Kuhn CM
J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276
[TBL] [Abstract][Full Text] [Related]
22. Use of serotonergic agents in the clinical assessment of central serotonin function.
Murphy DL; Mueller EA; Garrick NA; Aulakh CS
J Clin Psychiatry; 1986 Apr; 47 Suppl():9-15. PubMed ID: 3514586
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of substituted phenylethylamines on brain serotonergic mechanisms.
Chung Hwang E; Van Woert MH
J Pharmacol Exp Ther; 1980 May; 213(2):254-60. PubMed ID: 6965983
[TBL] [Abstract][Full Text] [Related]
24. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
D'Amato RJ; Largent BL; Snowman AM; Snyder SH
J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
[TBL] [Abstract][Full Text] [Related]
25. Citalopram: a new potent inhibitor of serotonin (5-HT) uptake with central 5-HT-mimetic properties.
Pawłowski L; Ruczyńska J; Górka Z
Psychopharmacology (Berl); 1981; 74(2):161-5. PubMed ID: 6267647
[TBL] [Abstract][Full Text] [Related]
26. Blockade of para-methoxyamphetamine induced serotonin release by serotonin uptake inhibitors.
Tseng LF
Proc West Pharmacol Soc; 1978; 21():7-9. PubMed ID: 308662
[No Abstract] [Full Text] [Related]
27. Fluvoxamine influences serotonergic system in the brain: neurochemical evidence.
Lapierre YD; Rastogi RB; Singhal RL
Neuropsychobiology; 1983; 10(4):213-6. PubMed ID: 6427651
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of 5-hydroxytryptamine accumulation and deamination by substituted phenylalkylamines in hypothalamic synaptosomes from normal and reserpine-pretreated rats.
Ask AL; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):591-6. PubMed ID: 2965308
[TBL] [Abstract][Full Text] [Related]
29. 1-[2-Amino-1-[1-(naphthyloxy)methyl] ethyl] piperidine hydrochloride: specific inhibition of brain serotonin uptake and related activities.
Pugsley TA; Lippmann W
Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):322-38. PubMed ID: 303505
[No Abstract] [Full Text] [Related]
30. Role of serotonin reuptake inhibition in the development of subsensitivity of the norepinephrine (NE) receptor coupled adenylate cyclase system.
Mishra R; Sulser F
Commun Psychopharmacol; 1978; 2(4):365-9. PubMed ID: 310378
[No Abstract] [Full Text] [Related]
31. Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine.
Lassen JB; Lund J; Søndergaard I
Psychopharmacology (Berl); 1980; 68(3):229-33. PubMed ID: 6446724
[No Abstract] [Full Text] [Related]
32. Biochemical and pharmacological tests for the prediction of ability of monoamine uptake blockers to inhibit the uptake of noradrenaline in-vivo: the effects of desipramine, maprotiline, femoxetine and citalopram.
Pawłowski L; Nowak G
J Pharm Pharmacol; 1987 Dec; 39(12):1003-9. PubMed ID: 2894425
[TBL] [Abstract][Full Text] [Related]
33. Brain 5-HT uptake sites, labelled with [3H]-paroxetine, in post-mortem samples from depressed suicide victims.
Lawrence KM; De Paermentier F; Cheetham SC; Crompton MR; Katona CL; Horton RW
Br J Pharmacol; 1989 Dec; 98 Suppl():812P. PubMed ID: 2532944
[No Abstract] [Full Text] [Related]
34. The effect of selective 5-hydroxytryptamine uptake inhibitors on 5-methoxy-N,N-dimethyltryptamine-induced ejaculation in the rat.
Rényi L
Br J Pharmacol; 1986 Apr; 87(4):639-48. PubMed ID: 2939912
[TBL] [Abstract][Full Text] [Related]
35. Selective effects of CGS 10686B, dl-fenfluramine or fluoxetine on nutrient selection.
Kim SH; Wurtman RJ
Physiol Behav; 1988; 42(4):319-22. PubMed ID: 2838855
[TBL] [Abstract][Full Text] [Related]
36. Effects of serotonin uptake blockers and of 5-hydroxytryptophan on the voluntary consumption of ethanol, water and solid food by UChA and UChB rats.
Alvarado R; Contreras S; Segovia-Riquelme N; Mardones J
Alcohol; 1990; 7(4):315-9. PubMed ID: 2143905
[TBL] [Abstract][Full Text] [Related]
37. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis.
Fuller RW
Life Sci; 1994; 55(3):163-7. PubMed ID: 8007758
[TBL] [Abstract][Full Text] [Related]
38. Structural requirements for uptake into serotoninergic neurones.
Ross SB; Ask AL
Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):270-7. PubMed ID: 7368945
[TBL] [Abstract][Full Text] [Related]
39. Failure to detect any transport of the irreversible monoamine oxidase inhibitor N-cyclopropyl-4-chloroamphetamine by the carrier of 5-hydroxytryptamine in the brain of the rat in vivo.
Fagervall I; Ross SB
Neuropharmacology; 1986 Aug; 25(8):911-3. PubMed ID: 3490629
[TBL] [Abstract][Full Text] [Related]
40. Role of the serotonin uptake carrier in the neurochemical response to methamphetamine: effects of citalopram and chlorimipramine.
Schmidt CJ; Gibb JW
Neurochem Res; 1985 May; 10(5):637-48. PubMed ID: 3859754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
